Found 24 results
Author Title [ Type(Asc)] Year
Filters: Author is Wolff, Mark  [Clear All Filters]
Journal Article
F. M. Munoz, Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Stephens, I., Ault, K., Winokur, P., Petrie, C. R., Wolff, M., Patel, S. M., and Keitel, W. A., Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women., Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
R. B. Belshe, Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., Spearman, P., Hill, H., and Wolff, M., Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant., J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
J. J. Treanor, Campbell, J. D., Zangwill, K. M., Rowe, T., and Wolff, M., Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine., N Engl J Med, vol. 354, no. 13, pp. 1343-51, 2006.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., Safety and immunogenicity of a candidate parvovirus B19 vaccine., Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
B. L. Rivoire, Groathouse, N. A., TerLouw, S., Neupane, K. Dev, Ranjit, C., Sapkota, B. Raj, Khadge, S., Kunwar, C. B., Kunwar, C. B., Macdonald, M., Hawksworth, R., Thapa, M. B., Hagge, D. A., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., Zhou, E., Makhene, M., Mason, R., Sizemore, C., and Brennan, P. J., Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study., PLoS Negl Trop Dis, vol. 8, no. 5, p. e2811, 2014.
A. C. Seña, Wolff, M., Behets, F., Van Damme, K., Martin, D. H., Leone, P., McNeil, L., and Hook, E. W., Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin., Clin Infect Dis, vol. 56, no. 3, pp. 420-2, 2013.
K. M. Holman, Wolff, M., Seña, A. C., Martin, D. H., Behets, F., Van Damme, K., Leone, P., McNeil, L., Gehrig, M. L., and Hook, E. W., Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy., Sex Transm Dis, vol. 39, no. 8, pp. 645-7, 2012.
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C., Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women., Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
A. C. Seña, Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P., Langley, C., McNeil, L., and Hook, E. W., Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis., Clin Infect Dis, vol. 53, no. 11, pp. 1092-9, 2011.
E. W. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A. C., Martin, D., Langley, C., McNeil, L., and Wolff, M., A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis., J Infect Dis, vol. 201, no. 11, pp. 1729-35, 2010.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., and Kotloff, K. L., Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009., Vaccine, vol. 30, no. 28, pp. 4240-8, 2012.
L. R. Baden, Liu, J., Li, H., Johnson, J. A., Walsh, S. R., Kleinjan, J. A., Engelson, B. A., Peter, L., Abbink, P., Milner, D. A., Golden, K. L., Viani, K. L., Stachler, M. D., Chen, B. J., Pau, M. G., Weijtens, M., Carey, B. R., Miller, C. A., Swann, E. M., Wolff, M., Loblein, H., Seaman, M. S., Dolin, R., and Barouch, D. H., Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans., J Infect Dis, vol. 211, no. 4, pp. 518-28, 2015.
T. S Callahan, Wolff, M., Hill, H. R., and Edwards, K. M., Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults., J Infect Dis, vol. 210, no. 8, pp. 1270-4, 2014.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., C Creech, B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. Rodeheffer, Wolff, M., and Edwards, K. M., Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women., J Infect Dis, vol. 204, no. 6, pp. 854-63, 2011.
N. Ali Goji, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., Rowe, T., and Treanor, J. J., Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant., J Infect Dis, vol. 198, no. 5, pp. 635-41, 2008.
L. R. Baden, Walsh, S. R., Seaman, M. S., Tucker, R. P., Krause, K. H., Patel, A., Johnson, J. A., Kleinjan, J., Yanosick, K. E., Perry, J., Zablowsky, E., Abbink, P., Peter, L., M Iampietro, J., Cheung, A., Pau, M. G., Weijtens, M., Goudsmit, J., Swann, E., Wolff, M., Loblein, H., Dolin, R., and Barouch, D. H., First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)., J Infect Dis, vol. 207, no. 2, pp. 240-7, 2013.
L. R. Baden, Walsh, S. R., Seaman, M. S., Johnson, J. A., Tucker, R. P., Kleinjan, J. A., Gothing, J. A., Engelson, B. A., Carey, B. R., Oza, A., Bajimaya, S., Peter, L., Bleckwehl, C., Abbink, P., Pau, M. G., Weijtens, M., Kunchai, M., Swann, E. M., Wolff, M., Dolin, R., and Barouch, D. H., First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)., J Infect Dis, vol. 210, no. 7, pp. 1052-61, 2014.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults., Vaccine, vol. 20, no. 7-8, pp. 1099-105, 2002.
M. Laassri, Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., and Chumakov, K., Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains., J Infect Dis, vol. 192, no. 12, pp. 2092-8, 2005.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., C Hay, M., Wolff, M., She, D., and Cox, M. M. J., Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults., J Infect Dis, vol. 193, no. 9, pp. 1223-8, 2006.
R. W. Frenck, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults., Vaccine, vol. 29, no. 34, pp. 5666-74, 2011.
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., C Creech, B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children., Pediatr Infect Dis J, vol. 33, no. 8, pp. 865-71, 2014.